1. Introduction 

Nanotechnology has emerged as a revolutionary field in modern science, offering innovative solutions across diverse disciplines such as medicine, materials science, electronics, and environmental engineering. In the biomedical domain, nanoparticles have gained significant attention due to their unique physicochemical properties, including high surface area-to-volume ratio, tunable size, enhanced reactivity, and the ability to interact with biological systems at the molecular and cellular levels [1]. These characteristics make nanoparticles highly suitable for applications in diagnostics, imaging, drug delivery, and targeted therapeutics. Targeted therapeutics represents a major advancement in modern medicine, aiming to deliver therapeutic agents specifically to diseased tissues while minimizing adverse effects on healthy cells [2]. Conventional drug delivery systems often suffer from poor bioavailability, lack of specificity, and systemic toxicity. Nanoparticle-based delivery systems address these limitations by enabling controlled drug release, improved pharmacokinetics, and precise targeting through surface functionalization. As a result, nanoparticles have become integral components of advanced therapeutic strategies, particularly in the treatment of complex diseases such as cancer, neurological disorders, and infectious diseases.

The methods of nanoparticle synthesis, including chemical and physical approaches, present several challenges. These methods often require hazardous chemicals, high energy input, and sophisticated equipment, which can lead to environmental concerns and potential toxicity in biomedical applications. Moreover, achieving precise control over nanoparticle size, shape, and surface characteristics using conventional methods can be difficult, limiting their effectiveness in clinical applications, green synthesis approaches have been developed, with a strong focus on biological systems and naturally derived compounds. Among these, the use of biomolecules for nanoparticle synthesis has gained considerable importance. Biomolecules such as proteins, enzymes, polysaccharides, lipids, and nucleic acids possess functional groups that enable them to interact with metal ions and facilitate nanoparticle formation under mild and environmentally friendly conditions [3]. These biomolecules not only act as reducing agents but also serve as stabilizing and capping agents, ensuring the formation of uniform and stable nanoparticles. The controlled biosynthesis of nanoparticles using biomolecules provides several advantages, including improved biocompatibility, reduced toxicity, and enhanced functional properties. This approach allows precise regulation of nanoparticle characteristics, which is critical for biomedical applications. Furthermore, biomolecule-mediated nanoparticles can be easily functionalized for targeted delivery, making them highly effective in therapeutic applications [4]. This review focuses on understanding the role of biomolecules in the controlled biosynthesis of nanoparticles and explores their potential applications in targeted therapeutics.

2. Role of Biomolecules in Nanoparticle Biosynthesis 

Biomolecules play a central and multifaceted role in the biosynthesis of nanoparticles by mediating the reduction, nucleation, growth, and stabilization processes. These molecules contain a variety of functional groups, such as hydroxyl, amino, carboxyl, and thiol groups, which enable them to bind metal ions and facilitate their transformation into nanoparticles. The presence and arrangement of these functional groups determine the efficiency of the reduction process as well as the stability and morphology of the resulting nanoparticles. Proteins are among the most widely utilized biomolecules in nanoparticle biosynthesis due to their structural complexity and functional versatility. They can act as both reducing agents and capping agents, controlling nanoparticle formation and preventing aggregation. Specific amino acid residues within proteins, such as cysteine and tyrosine, play a crucial role in binding metal ions and stabilizing the nanoparticles [5]. Additionally, proteins can serve as templates that guide the formation of nanoparticles with specific structures, thereby enabling precise control over particle morphology. Enzymes, which are specialized proteins with catalytic properties, further enhance the efficiency of nanoparticle biosynthesis. They facilitate rapid and controlled reduction of metal ions under mild conditions, making the process highly efficient and reproducible. Enzyme-mediated synthesis is particularly advantageous because it allows for selective and site-specific nanoparticle formation, which is essential for biomedical applications.

Polysaccharides such as chitosan, cellulose, and starch also play a significant role in nanoparticle biosynthesis. These biopolymers provide a supportive matrix that stabilizes nanoparticles and prevents aggregation. Their biocompatibility and biodegradability make them ideal candidates for biomedical applications. Furthermore, polysaccharides can enhance the functional properties of nanoparticles by improving their solubility, stability, and interaction with biological systems. Nucleic acids, including DNA and RNA, have emerged as promising biomolecules for nanoparticle synthesis due to their ability to form well-defined and programmable structures. They can bind metal ions through their phosphate backbone and nitrogenous bases, enabling the formation of highly organized nanostructures. This property is particularly useful for designing nanoparticles with specific functionalities for targeted therapeutic applications. Lipids, on the other hand, contribute to the formation of lipid-based nanoparticles, which are widely used in drug delivery systems. These nanoparticles can encapsulate both hydrophilic and hydrophobic drugs, providing a versatile platform for targeted delivery. Lipid molecules also enhance the biocompatibility and stability of nanoparticles, making them suitable for in vivo applications [6]. The controlled biosynthesis of nanoparticles using biomolecules is influenced by various factors, including pH, temperature, concentration of biomolecules, and reaction time. By carefully optimizing these parameters, it is possible to achieve nanoparticles with desired size, shape, and surface properties. This level of control is essential for tailoring nanoparticles to specific biomedical applications, particularly in targeted therapeutics where precision and efficiency are critical, biomolecules not only enable the sustainable synthesis of nanoparticles but also provide a high degree of control over their physicochemical properties. Their multifunctional role in nanoparticle biosynthesis makes them indispensable for the development of advanced nanomaterials for therapeutic applications.

3. Mechanisms of Controlled Biosynthesis 

The controlled biosynthesis of nanoparticles is a complex and highly regulated process that involves a sequence of biochemical reactions influenced by the nature of biomolecules and the surrounding synthesis conditions. The process typically begins with the reduction of metal ions into their zero-valent state, which is facilitated by biomolecules acting as electron donors. Functional groups such as hydroxyl, amino, and thiol groups present in biomolecules interact with metal ions, initiating their conversion into nanoscale particles. This reduction step is critical, as it determines the initial formation and chemical composition of the nanoparticles. Following reduction, nucleation occurs, where reduced atoms cluster together to form small, stable nuclei [7]. These nuclei serve as seeds for further growth, during which additional atoms accumulate to increase particle size. The rate of nucleation and growth plays a crucial role in determining the final size and distribution of nanoparticles. Biomolecules influence these processes by controlling the availability of metal ions and stabilizing intermediate structures, thereby ensuring uniform particle formation.

Stabilization is another essential aspect of controlled biosynthesis. Biomolecules act as capping agents by forming a protective layer around nanoparticles, preventing aggregation and ensuring long-term stability. This capping process not only maintains uniform particle size but also enhances compatibility with biological systems. Furthermore, biomolecules can direct the morphology of nanoparticles by selectively binding to specific crystal facets, leading to the formation of distinct shapes such as spherical, rod-like, cubic, or triangular structures. The ability to control nanoparticle morphology is particularly important, as shape significantly influences biological interactions and therapeutic performance. Environmental parameters such as pH, temperature, reaction time, and biomolecule concentration play a pivotal role in regulating the biosynthesis process. For instance, pH can affect the ionization state of functional groups, thereby influencing their binding efficiency with metal ions. Temperature impacts reaction kinetics and nanoparticle growth rates, while biomolecule concentration determines the availability of reducing and stabilizing agents. By carefully optimizing these parameters, researchers can achieve precise control over nanoparticle size, shape, and surface characteristics, enabling the design of nanoparticles tailored for specific biomedical applications.

4. Applications in Targeted Therapeutics 

Biosynthesized nanoparticles have emerged as highly effective tools in targeted therapeutics due to their ability to deliver drugs selectively to diseased tissues while minimizing adverse effects on healthy cells. Their small size, large surface area, and ease of functionalization enable them to interact efficiently with biological systems and penetrate cellular barriers. One of the most significant applications of these nanoparticles is in cancer therapy, where they are used to deliver anticancer drugs directly to tumor sites. By exploiting mechanisms such as enhanced permeability and retention effect and ligand-based targeting, nanoparticles can accumulate in tumor tissues, thereby increasing drug concentration at the target site and reducing systemic toxicity, biosynthesized nanoparticles play a crucial role in gene therapy. They act as carriers for nucleic acids such as DNA and RNA, facilitating their safe and efficient delivery into target cells. Biomolecule-functionalized nanoparticles can be designed to recognize specific receptors on cell surfaces, enabling precise targeting and improving gene transfer efficiency [8]. This approach holds great promise for the treatment of genetic disorders and other complex diseases. Another important application is in diagnostic imaging and disease detection. Nanoparticles can be engineered with imaging agents or fluorescent markers, allowing them to serve as contrast agents in techniques such as magnetic resonance imaging and fluorescence imaging. This enhances the sensitivity and accuracy of disease detection, enabling early diagnosis and timely intervention. Controlled drug release is another key advantage of nanoparticle-based systems. Biosynthesized nanoparticles can be designed to release therapeutic agents in a sustained and controlled manner, either through passive diffusion or in response to specific stimuli such as pH, temperature, or enzymatic activity. This controlled release improves therapeutic outcomes, reduces dosing frequency, and enhances patient compliance. The combination of targeting capability, biocompatibility, and multifunctionality makes biosynthesized nanoparticles highly promising for advanced therapeutic applications.

5. Challenges and Limitations 

The potential of biomolecule-mediated nanoparticle synthesis, several challenges and limitations must be addressed to ensure their effective application in therapeutics. One of the primary concerns is the variability in biomolecule composition, which can lead to inconsistencies in nanoparticle synthesis. Since biomolecules derived from natural sources may vary in composition depending on environmental and biological factors, achieving reproducibility and uniformity in nanoparticle characteristics can be challenging. Standardization of synthesis protocols and careful control of experimental conditions are essential to overcome this issue [9-10]. Another significant challenge is the scalability of the biosynthesis process. While laboratory-scale synthesis has been successfully demonstrated, translating these methods to industrial-scale production requires optimization of process parameters to ensure cost-effectiveness, efficiency, and consistency. Maintaining the stability and functionality of nanoparticles during large-scale production and storage is also a critical concern. The stability of nanoparticles in biological environments presents another limitation. Nanoparticles may undergo aggregation, degradation, or interaction with biological components, which can affect their performance and therapeutic efficacy. Additionally, although biosynthesized nanoparticles are generally considered less toxic than chemically synthesized counterparts, their potential toxicity and long-term effects must be thoroughly evaluated. Comprehensive toxicological studies are necessary to assess their safety for clinical applications. Regulatory challenges further complicate the development and commercialization of nanoparticle-based therapeutics. The approval process for such technologies involves rigorous testing and compliance with safety standards, which can be time-consuming and costly. Clear regulatory guidelines and standardized evaluation methods are needed to facilitate the translation of this technology from research to clinical practice.

6. Future Perspectives and Research Directions 

The future of biomolecule-mediated nanoparticle biosynthesis lies in the development of more advanced, efficient, and multifunctional nanomaterials for targeted therapeutics. Ongoing research is focused on improving the precision and control of nanoparticle synthesis by exploring new biomolecules and optimizing reaction conditions [11]. Advances in molecular biology and nanotechnology are expected to enable the design of nanoparticles with enhanced targeting capabilities, improved stability, and greater therapeutic efficiency. The integration of computational tools, including artificial intelligence and machine learning, is emerging as a powerful approach for optimizing nanoparticle design and synthesis. These technologies can analyze large datasets to predict optimal synthesis conditions and nanoparticle properties, thereby accelerating the development of customized nanomaterials for specific applications.

The development of hybrid nanoparticles that combine multiple biomolecules is another promising research direction. Such nanoparticles can exhibit synergistic properties, combining the advantages of different biomolecules to enhance targeting specificity, drug loading capacity, and therapeutic effectiveness. Additionally, research is focused on developing stimuli-responsive nanoparticles that can release drugs in response to specific biological signals, further improving treatment precision. Efforts to develop cost-effective and scalable production methods are also critical for the commercialization of biosynthesized nanoparticles. Interdisciplinary collaboration among scientists, engineers, and healthcare professionals will play a key role in addressing existing challenges and advancing this field. With continued innovation, biomolecule-mediated nanoparticle synthesis is expected to revolutionize targeted therapeutics and contribute significantly to modern healthcare.

7. Conclusion 

Biomolecules play a fundamental role in the controlled biosynthesis of nanoparticles, offering a sustainable, efficient, and versatile approach for producing biocompatible nanomaterials. Their ability to mediate reduction, stabilization, and functionalization processes enables precise control over nanoparticle properties, which is essential for biomedical applications. Biosynthesized nanoparticles have demonstrated significant potential in targeted therapeutics, particularly in drug delivery, gene therapy, and diagnostic imaging, where precision and safety are critical. Although several challenges remain, including issues related to reproducibility, scalability, stability, and regulatory approval, ongoing research and technological advancements are steadily addressing these limitations. The integration of advanced tools such as artificial intelligence, along with the development of multifunctional and hybrid nanoparticles, is expected to further enhance the capabilities of this technology, biomolecule-mediated nanoparticle biosynthesis represents a promising and rapidly evolving field with the potential to transform modern medicine. 

References

1. Veerapandian, M., & Yun, K. (2011). Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications. Applied microbiology and biotechnology, 90(5), 1655-1667.
2. Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020). Therapeutic nanoparticles and their targeted delivery applications. Molecules, 25(9), 2193.
3. Krishna, R. H., Chandraprabha, M. N., Monika, P., Br, T., Chaudhary, V., & Manjunatha, C. (2024). Biomolecule conjugated inorganic nanoparticles for biomedical applications: A review. Biotechnology and Genetic Engineering Reviews, 40(4), 3611-3652.
4. Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., … & Cai, L. (2023). Smart nanoparticles for cancer therapy. Signal transduction and targeted therapy, 8(1), 418.
5. Sv, S., Augustine, D., Hosmani, J., Pagnoni, F., Reda, R., Testarelli, L., & Patil, S. (2024). Nanoparticle-based biomolecules in cancer diagnosis, therapy, drug delivery and prognosis. Frontiers in Dental Medicine, 5, 1482166.
6. Karunakaran, G., Sudha, K. G., Ali, S., & Cho, E. B. (2023). Biosynthesis of nanoparticles from various biological sources and its biomedical applications. Molecules, 28(11), 4527.
7. Sapsford, Kim E., W. Russ Algar, Lorenzo Berti, Kelly Boeneman Gemmill, Brendan J. Casey, Eunkeu Oh, Michael H. Stewart, and Igor L. Medintz. “Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology.” Chemical reviews 113, no. 3 (2013): 1904-2074.
8. Yang, Y., Zhang, M., Song, H., & Yu, C. (2020). Silica-based nanoparticles for biomedical applications: from nanocarriers to biomodulators. Accounts of chemical research, 53(8), 1545-1556.
9. Auría-Soro, C., Nesma, T., Juanes-Velasco, P., Landeira-Viñuela, A., Fidalgo-Gomez, H., Acebes-Fernandez, V., … & Fuentes, M. (2019). Interactions of nanoparticles and biosystems: microenvironment of nanoparticles and biomolecules in nanomedicine. Nanomaterials, 9(10), 1365.
10. Zhang, S., Zhang, X., & Su, Z. (2020). Biomolecule conjugated metal nanoclusters: bio-inspiration strategies, targeted therapeutics, and diagnostics. Journal of Materials Chemistry B, 8(19), 4176-4194.
11. He, P., Yang, G., Zhu, D., Kong, H., Corrales-Urena, Y. R., Colombi Ciacchi, L., & Wei, G. (2022). Biomolecule-mimetic nanomaterials for photothermal and photodynamic therapy of cancers: Bridging nanobiotechnology and biomedicine. Journal of Nanobiotechnology, 20(1), 483.